Venky's (India) Limited Q2 Results Due on 13 November

Venky's (India) Limited is scheduled to report Q2 FY27 results on 13 November 2026 after recording Q1 FY27 revenue of ₹1,118 crore, up 29.1% year on year, and net profit of ₹50 crore, up 212.5%. The release will indicate whether the recovery in poultry pricing and the improvement in oilseed operations continued through September.

When will Venky's (India) report Q2 FY27 results?

Venky's (India) is scheduled to announce its financial results for the July-September 2026 quarter on Friday, 13 November 2026. The board is expected to consider and approve the Q2 FY27 and H1 FY27 audited results at its meeting on that date, according to the company's 23 October filing with the NSE.

The reporting date falls 44 days after the end of the September quarter. Listed companies are required to publish quarterly results within 45 days of the quarter-end, except for the January-March quarter, when the deadline is 60 days. The company has also scheduled a Q2 FY27 results conference call for 16 November 2026 at 2:30 pm IST. Management representatives from the poultry, animal health products and oilseed segments, along with the chief financial officer and company secretary, are expected to participate.

What did Venky's (India) report in Q1 FY27?

Venky's (India) reported a sharp year-on-year recovery in Q1 FY27, with revenue rising to ₹1,118 crore and net profit reaching ₹50 crore. The June 2026 quarter marked a reversal from the weak earnings conditions reflected in the comparable quarter a year earlier, when revenue was ₹866 crore and net profit was ₹16 crore.

The company reported EBITDA of ₹69 crore for the June quarter, compared with ₹24 crore in June 2025. Earnings per share rose to ₹35.49 from ₹11.24. The reported improvement was linked to stronger poultry realisations and better performance in the oilseed business, where volume and margin conditions improved.

The sequential comparison also shows that Q1 EBITDA and profit were below the March 2026 quarter, when EBITDA was ₹130 crore and net profit was ₹97 crore. This makes the Q2 release relevant for assessing whether the Q1 recovery can be sustained rather than viewed only against a low year-ago base.

Which operating metrics matter in Venky's (India) Q2 FY27 results?

Poultry segment profitability, oilseed margins and animal health products growth are the main operating metrics to watch in Venky's (India)'s Q2 FY27 release. Market expectations cited ahead of the results place quarterly revenue in a range of about ₹1,100 crore to ₹1,150 crore, broadly in line with the ₹1,118 crore reported in Q1.

Broiler pricing has reportedly remained above the cost of production since late October, with guidance extending through March. Management has indicated that profitable poultry pricing could continue in the second half of FY27. Poultry EBIT therefore remains the largest swing factor for the company's full-year profit performance.

The oilseed business is also important because its utilisation is reported to be close to the company's 80% FY27 target. Oilseed EBIT margin guidance is around 3% for the year, with an indicated range of about 2.5% to 3.5%. The available outlook links further margin movement largely to volumes and soybean price conditions. For animal health products, management has guided for double-digit FY27 growth, supported by new product launches and the ramp-up of the Kesavadi facility.

How could the Q2 update affect investors and the poultry sector?

The Q2 update will provide a current check on the assumptions behind expected FY27 revenue growth of 15% to 18% and profit after tax growth of 15% to 20%. Those expectations are based on sustained poultry recovery and a more normalised contribution from oilseeds, rather than on a disclosed Q2 result, which had not been announced at the time of the scheduled reporting date.

For investors, the key issue is whether segment-level profitability supports the improvement seen in Q1. Consensus cited in the available data places the target price at ₹2,270 against a stated current level of ₹1,616, implying about 40% upside. This is an estimate, not a company forecast, and depends on the operating assumptions being met.

The release also matters for the wider poultry supply chain because broiler realisations relative to production costs affect farm-level economics and integrated poultry operators. Venky's (India) operates across poultry, processed food, animal health products and oilseeds, so management commentary may show whether conditions differ across these businesses. The 16 November conference call is expected to provide additional segment-specific discussion after the financial results are filed.

Conclusion

Venky's (India) enters its Q2 FY27 results with a stronger Q1 base, having reported ₹1,118 crore of revenue and ₹50 crore of net profit. The September-quarter filing will show whether stronger poultry realisations, improved oilseed performance and animal health products growth translated into another period of positive operating momentum.

Investors will watch the 13 November results for poultry EBIT, oilseed margin and revenue trends, followed by management's 16 November conference call. The disclosed full-year reference points remain oilseed utilisation near 80%, oilseed EBIT margins around 3%, and the company's guidance for double-digit growth in animal health products.